Issues and Optimization Suggestions in the Implementation of Post-Marketing Quality Sampling and Testing Requirements for Pharmaceutical Products and Medical Devices

Xue Jing, Zhong Xuanwei, Huang Baobin, Li Ying, Jiang Yingjun

Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (10) : 1108-1113.

PDF(956 KB)
PDF(956 KB)
Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (10) : 1108-1113. DOI: 10.16153/j.1002-7777.2025-05-0019
Supervision & Administration

Issues and Optimization Suggestions in the Implementation of Post-Marketing Quality Sampling and Testing Requirements for Pharmaceutical Products and Medical Devices

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 39(10): 1108-1113 https://doi.org/10.16153/j.1002-7777.2025-05-0019

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(956 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉